New classes of glaucoma medications
Related Experiment Video
Updated: Mar 12, 2026

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
Published on: March 12, 2016
Emily M Schehlein1, Gary D Novack, Alan L Robin
1aUniversity of Maryland School of Medicine, Department of Ophthalmology and Visual Sciences, Baltimore, Maryland bPharmaLogic Development Inc., San Rafael, California, USA cDepartments of Pharmacology and Ophthalmology, University of California, Davis, School of Medicine, California dUniversity of Michigan, Department of Ophthalmology and Visual Sciences, Ann Arbor, Michigan eJohns Hopkins University Department of Ophthalmology and School of Public Health, Baltimore, Maryland, USA.
Purpose Of Review:
To discuss recent advances in the medical management of glaucoma and to highlight future medical therapies currently in development.
Recent Findings:
In 1996, latanoprost (Xalatan) was approved in the United States as a new chemical entity and new class (prostaglandin analogs) for the topical treatment of ocular hypertension and glaucoma. In the period from the late 1990s-2010s, while there were additional new chemical entities, fixed dose combinations, and formulation improvements, there were no new classes of ocular hypotensive medications approved worldwide. We summarize new pharmacological treatments that are currently in clinical trials - new classes, new molecules and new delivery systems.
Summary:
Although challenges in medical treatment of glaucoma exist, particularly in patient adherence, medical therapy remains the first line treatment for almost all glaucoma patients. Few new medications for glaucoma therapy are currently available for our patients, but multiple drugs with novel mechanisms of action, new formulations, and new delivery mechanisms are currently in development.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Ophthalmic Drug Delivery Systems
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

